Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight
In conclusion, MAFLD represents a higher risk than obesity for COVID-19 severity, resulting in poor outcomes and even progression to non-alcoholic steatohepatitis. Hepatologists should include MAFLD subjects in the high-risk group, intensify preventive measurements, and prioritize their vaccination.PMID:33967554 | PMC:PMC8072197 | DOI:10.3748/wjg.v27.i16.1738
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Isabela Macedo Lopes Vasques-Monteiro Vanessa Souza-Mello Source Type: research
More News: Alcoholism | Coronavirus | COVID-19 | Eating Disorders & Weight Management | Fatty Liver Disease (FLD) | Gastroenterology | Hypertension | Liver | Liver Disease | Obesity | Outbreaks | Urology & Nephrology | Vaccines